Shuli Kulak M.D.

Shuli Kulak MD, MBA, serves as the Head of Corporate Strategy & BD at Solid Biosciences since December 2022 and is a Venture Partner at Deep Science Ventures since March 2020. Previously, Shuli held the position of Head of Corporate Strategy & BD at AavantiBio, Inc. until its acquisition by Solid Biosciences in January 2023. Additional experience includes roles such as Head of Strategy at Lonza and Director of Corporate Strategy and Business Development at BioMarin Pharmaceutical Inc. Prior to these positions, Shuli was the Director of New Business Development for Rare Pediatric Diseases at Fortress Biotech and worked as a Physician at Montefiore Medical Center. Early career experience includes serving as an IRB Administrator at Albert Einstein College of Medicine. Educationally, Shuli earned a Doctor of Medicine from Albert Einstein College of Medicine and an MBA from Sy Syms School of Business, along with a Bachelor of Arts from Yeshiva University.